Cordon Genomics

Lucknow, India
Provides next-generation sequencing, PCR tests, and full body checkups for diagnostics.

About Cordon Genomics

Cordon Genomics is a Healthcare company based in Lucknow (India). It provides next-generation sequencing, PCR tests, and full body checkups for diagnostics. It operates on a B2B and D2C model. Its Indian entity Cordon Genomics Private Limited reported revenue of β‚Ή76.4 Lakh. Cordon Genomics offers products and services including NGS Test, Real Time PCR Test, Full Body Checkup, and Gut Microbiome Analysis. Its focus areas include Wellness, Preventive Care, Full Body Checkups and Genomics. Its competitors include Prenetics, OpGen, Day Zero Diagnostics, Access Bio and Clear Labs and 5 more; 8 of its 10 listed competitors have raised funding.

Company details

Cordon Genomics specializes in advanced diagnostic services, including next-generation sequencing for genomic analysis and real-time PCR tests for detecting infections. They offer full body checkups and specialized tests like gut microbiome and prenatal screening. Operating in Indian cities such as Kanpur, Lucknow, and Varanasi, they serve healthcare providers and patients with personalized treatment solutions based on quick results.

Key Metrics
  • Annual Revenue
    ₹76.4 Lakh

    FY 2025 · +20% YoY

  • Net Profit
    ₹1.2 Lakh

    FY 2025 · 2% margin

  • EBITDA
    ₹6.4 Lakh

    FY 2025 · 8% margin

  • Employee Count
    1

Products & Services of Cordon Genomics

Cordon Genomics offers a comprehensive portfolio of products and services, including NGS Test, Real Time PCR Test, Full Body Checkup, and Gut Microbiome Analysis.

NGS Test
Genomic Sequencing

Next-generation sequencing for DNA analysis and personalized medicine.

Real Time PCR Test
Infectious Disease Diagnostics

Quantitative PCR for detecting pathogens in various conditions.

Full Body Checkup
Health Screening

Comprehensive tests for overall health monitoring and diagnostics.

Gut Microbiome Analysis
Microbiome Testing

Sequencing test to analyze gut bacteria for health insights.

Board of directors of Cordon Genomics Private Limited (Cordon Genomics)

Cordon Genomics Private Limited is the primary company behind Cordon Genomics. The board of Cordon Genomics Private Limited currently have 3 directors; the longest-serving is Arti Ahlawat, appointed in 2021.

DirectorDesignationAppointedTenureEntity
Arti Ahlawat
DIN 09187593
Director29 May 20215 yrs 4 moCordon Genomics Private Limited
Arvind Kumar
DIN 09187541
Director29 May 20215 yrs 4 moCordon Genomics Private Limited
Kuldeep Singh
DIN 09187542
Director29 May 20215 yrs 4 moCordon Genomics Private Limited

Financials of Cordon Genomics

Figures of Cordon Genomics Private Limited, the primary company behind Cordon Genomics, for FY 2025. Revenue was ₹76.4 Lakh (+20% year on year). Net profit was ₹1.2 Lakh (2% margin). EBITDA was ₹6.4 Lakh (8% margin).

  • ₹76.4 LakhRevenue · FY 2025 · +20% YoY
  • ₹1.2 LakhNet profit · 2% margin
  • ₹6.4 LakhEBITDA · 8% margin
  • ₹2 LakhPaid-up capital

Balance sheet, profit and loss, cash flow and ratios of Cordon Genomics Private Limited are on its company page.

Premium access

Detailed financial statements for Cordon Genomics

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Competitors of Cordon Genomics

Cordon Genomics has 10 listed competitors in our database, 8 of them funded. They include Prenetics, OpGen, Day Zero Diagnostics, Access Bio and Clear Labs, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
prenetics.com2009Hong Kong, China$67.65M–
Health risks are identified through online genetic and diagnostic testing.
opgen.com2002Rockville, United States$77.51M100
Developer of diagnostics and bioinformatics platforms for providers
dayzerodiagnostics.com2016Boston, United States$48.6M48
Genome sequencing diagnostics for infectious diseases are developed.
accessbio.net2001Somerset, United States$22M52
In vitro rapid diagnostic tests, biosensor, and molecular diagnostic products for diagnosis of infectious diseases.
clearlabs.com2014Menlo Park, United States$171.09M55
Food safety technologies are provided for pathogen identification.
sdbiosensor.com2001Suwon-si, South Korea––
Biosensors for point-of-care diagnostics are developed by SD Biosensor.
kariusdx.com2014Redwood, United States$315M139
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
curetis.com2007Holzgerlingen, Germany$127.14M55
Molecular diagnostics platform is provided for infectious disease detection.
seegene.com2000Seoul, South Korea––
Developer of molecular diagnostic kits to detect infectious and genetic diseases
lumosdiagnostics.com2017Carlsbad, United States$40M–
Diversified diagnostic assays and readers are developed for point-of-care use.
Premium access

Detailed competitors of Cordon Genomics

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Wellness & Preventive Health

10 companies that operate in the same segment as Cordon Genomics (Wellness & Preventive Health), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Provider of fitness memberships encompassing group classes, gyms, and at-home workouts
2016Bengaluru, Karnataka, IndiaUSD 716.99 M–1,832
Fitness class memberships are offered across various gyms and studios.
2013New York, New York, United StatesUSD 550 M–969
Operates and franchises fitness clubs
2002–USD 4.49 M–340
Investment and holding company
1970London, England, United KingdomUSD 118.2 M––
Operator of fitness chain
1992Newington, United States–USD 1.32 B3,810
Chain of fitness centers
2003West Jordan, Utah, United StatesUSD 200 MUSD 61.52 K–
Provider of group fitness classes and interval training programs. These programs combine strength and cardio training to improve metabolism and bui...
2010Boca Raton, Florida, United StatesUSD 250 M––
Chain of fitness centers
1992Chanhassen, Minnesota, United States–USD 3 B42,000
Health and wellness services are provided through multiple therapies.
2015Austin, Texas, United StatesUSD 176.53 M––
Equinox is recognized as a premium fitness and wellness provider.
1991New York, New York, United States–––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Cordon Genomics

Cordon Genomics is headquartered in Lucknow, India. It is registered at Lucknow, Uttar Pradesh, India.

Cordon Genomics has 1 employees.

The primary company behind Cordon Genomics, Cordon Genomics Private Limited, reported revenue of β‚Ή76.4 Lakh for FY 2025, up 20% year on year.

Cordon Genomics specializes in advanced diagnostic services, including next-generation sequencing for genomic analysis and real-time PCR tests for detecting infections. They offer full body checkups and specialized tests like gut microbiome and prenatal screening. Operating in Indian cities such as Kanpur, Lucknow, and Varanasi, they serve healthcare providers and patients with personalized treatment solutions based on quick results.

Cordon Genomics's top competitors include Prenetics, Clear Labs and Day Zero Diagnostics.

Cordon Genomics offers NGS Test, Real Time PCR Test, Full Body Checkup, and Gut Microbiome Analysis.

Cordon Genomics operates through Cordon Genomics Private Limited.

The legal entities of Cordon Genomics currently have 3 directors, including Arti Ahlawat, Arvind Kumar, Kuldeep Singh.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available